According to the clinical trial transparency and compliance solutions provider, ATLAS Global Compliance enables sponsors to ensure trials are compliant by consolidating information from all trial sites into one view.
“ATLAS Global Compliance reduces risks and costs associated with clinical trial disclosure non-compliance,” Mark Heinold, CEO, TrialScope, told Outsourcing-Pharma.com.
The SaaS solution provides clinical trial sponsors with the ability to reference a library of local disclosure rules to guide and prioritize disclosure activities, which Heinold said reduces the costs of “researching and maintaining an organizational understanding of local rules.”
As Heinold explained, “the real-time views enable sponsors to manage future compliance deadlines while still offering a look back at disclosure performance against policies or regulations,” he said, adding that the insight is of particular value for companies entering new markets.
Additionally, the solution helps institutionalize requirements information traditionally kept in spreadsheets and local databases.
“Many sponsors have robust clinical trial disclosure programs but can’t answer the question, ‘Am I compliant?’ in the markets where they operate,” said Heinold. “ATLAS Global Compliance applies local requirements within the tracking tool to help sponsors to disclose locally and comply globally.”